Improved method for the intracerebral engraftment of tumour cells and intratumoural treatment using a guide screw system in mice
- PMID: 14505105
- DOI: 10.1007/s00701-003-0091-5
Improved method for the intracerebral engraftment of tumour cells and intratumoural treatment using a guide screw system in mice
Abstract
Background: Orthotopic in vivo models for the experimental treatment of malignant gliomas have become indispensable to evaluate the efficacy of novel therapeutic regimens. Recently, a guide screw system was introduced which is implanted into the cranium of small rodents where it facilitates fast, repeated and exactly reproducible intracerebral injections, avoiding time consuming stereotactic procedures. Here we report our experience with this system, and describe several modifications which we introduced to improve its reliability and to simplify its application.
Findings: The most important modification made was the optimization of the guide screw implantation site, which needs to be adapted to the age of the mice. Other improvements were the fixation of the guide screw to the cranium of the mice using a two component adhesive. This avoids the tendency, when daily intratumoural injections are performed over several weeks, for the screw to loosen, making precise injections impossible. The injection procedure, initially described as a free-hand approach, was improved by mounting the syringe to a Greenberg retractor. This provided additional stability and speeded up the process. Applying this modified technique, we were able to achieve reproducible results with regard to engraftment rate, tumour growth, and intratumoural treatment in immunocompromized mice.
Interpretation: We introduced several major and some minor improvements to make working with the guide screw system more reliable, faster and more comfortable. Daily injections over a period of three weeks using this system are feasible and well tolerated by mice.
Similar articles
-
An implantable guide-screw system for brain tumor studies in small animals.J Neurosurg. 2000 Feb;92(2):326-33. doi: 10.3171/jns.2000.92.2.0326. J Neurosurg. 2000. PMID: 10659021
-
A model for intratumoural chemotherapy in the rat brain.Acta Neurochir (Wien). 2004 Jul;146(7):731-4. doi: 10.1007/s00701-004-0261-0. Epub 2004 May 13. Acta Neurochir (Wien). 2004. PMID: 15197617
-
Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4.Clin Cancer Res. 2003 Oct 1;9(12):4578-85. Clin Cancer Res. 2003. PMID: 14555533
-
Experimental iodine-125 seed irradiation of intracerebral brain tumors in nude mice.Radiat Oncol. 2007 Sep 26;2:38. doi: 10.1186/1748-717X-2-38. Radiat Oncol. 2007. PMID: 17897452 Free PMC article.
-
Mouse orthotopic models for bladder cancer research.BJU Int. 2009 Nov;104(9):1286-91. doi: 10.1111/j.1464-410X.2009.08577.x. Epub 2009 Apr 16. BJU Int. 2009. PMID: 19388981 Review.
Cited by
-
Oncogenic role of p53 is suppressed by si-RNA bicistronic construct of uPA, uPAR and cathepsin-B in meningiomas both in vitro and in vivo.Int J Oncol. 2011 Apr;38(4):973-83. doi: 10.3892/ijo.2011.934. Epub 2011 Feb 2. Int J Oncol. 2011. Retraction in: Int J Oncol. 2021 Apr;58(4):6. doi: 10.3892/ijo.2021.5186. PMID: 21290090 Free PMC article. Retracted.
-
RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis.Int J Oncol. 2007 Jul;31(1):5-17. Int J Oncol. 2007. PMID: 17549400 Free PMC article.
-
RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo.Neuro Oncol. 2011 Oct;13(10):1074-89. doi: 10.1093/neuonc/nor098. Epub 2011 Jul 25. Neuro Oncol. 2011. PMID: 21788344 Free PMC article.
-
Inhibition of invasion-associated thromboxane synthase sensitizes experimental gliomas to gamma-radiation.J Neurooncol. 2009 Feb;91(3):241-9. doi: 10.1007/s11060-008-9708-0. Epub 2008 Sep 30. J Neurooncol. 2009. PMID: 18825315
-
RNAi-mediated abrogation of cathepsin B and MMP-9 gene expression in a malignant meningioma cell line leads to decreased tumor growth, invasion and angiogenesis.Int J Oncol. 2007 Nov;31(5):1039-50. Int J Oncol. 2007. PMID: 17912429 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical